Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank38
3Y CAGR+7.6%
5Y CAGR-8.0%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+7.6%/yr
vs -14.0%/yr prior
5Y CAGR
-8.0%/yr
Recent acceleration
Acceleration
+21.6pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.05 | +71.3% |
| 2024 | 1.20 | -31.9% |
| 2023 | 1.76 | +6.9% |
| 2022 | 1.65 | -44.3% |
| 2021 | 2.96 | -5.2% |
| 2020 | 3.12 | -27.9% |
| 2019 | 4.33 | +43.8% |
| 2018 | 3.01 | -98.3% |
| 2017 | 172.99 | - |